Philippe H Beaune
Overview
Explore the profile of Philippe H Beaune including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Villoutreix B, Beaune P, Tamouza R, Krishnamoorthy R, Leboyer M
Drug Discov Today
. 2020 Jun;
25(8):1287-1290.
PMID: 32593662
No abstract available.
2.
Ellero-Simatos S, Claus S, Benelli C, Forest C, Letourneur F, Cagnard N, et al.
J Proteome Res
. 2011 Oct;
10(12):5493-502.
PMID: 22017230
Adipose tissue is a major storage site for lipophilic environmental contaminants. The environmental metabolic disruptor hypothesis postulates that some pollutants can promote obesity or metabolic disorders by activating nuclear receptors...
3.
Berge M, Guillemain R, Tregouet D, Amrein C, Boussaud V, Chevalier P, et al.
Eur J Clin Pharmacol
. 2010 Nov;
67(3):253-60.
PMID: 21038076
Purpose: Voriconazole is widely used to treat invasive aspergillosis after lung transplantation. In cystic fibrosis patients, the interindividual variability in drug disposition complicates the optimal voriconazole dosing and increases the...
4.
Bodin L, Beaune P, Loriot M
J Biomed Biotechnol
. 2005 Sep;
2005(3):248-53.
PMID: 16192683
Gene dosage by real-time quantitative PCR has proved to be accurate for measuring gene copy number. The aim of this study was to apply this approach to the CYP2D6 gene...
5.
Morin S, Bodin L, Loriot M, Thijssen H, Robert A, Strabach S, et al.
Clin Pharmacol Ther
. 2004 Apr;
75(5):403-14.
PMID: 15116053
Objective: The aim of this study was to investigate the respective contribution of the different cytochrome P450 (CYP) 2C9 genetic polymorphisms to the interindividual variability of acenocoumarol pharmacodynamic response. Methods:...